Abstract
The efficacy of Adaptol (a non-benzodiazepine tranquilizer) in the treatment of children with attention deficit hyperactivity disorder (ADHD) was studied. At a dose of 500 mg twice daily for one month, Adaptol decreased hyperactivity and impulsivity without producing significant changes in attention or reaction times (the authors emphasize the importance of this factor, as we are dealing with side effects often encountered when benzodiazepine tranquilizers are used). These results lead to the conclusion that Adaptol can be used in the treatment of ADHD as monotherapy in cases in which there is a predominance of hyperactivity/impulsivity and as a component of complex therapy in other types of the disorder, particularly when ADHD is combined with anxiety disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
